THE EFFECT OF TRACHOMA VIRUS VACCINE ON THE COURSE OF EXPERIMENTAL TRACHOMA INFECTION IN BLIND HUMAN VOLUNTEERS

Abstract

The results of bacteriologic cultures of six volunteers provided important evidence that the large virus agents isolated from trachomatous eyes are the etiologic agent of trachoma and have shown that vaccine prepared from egg yolk sac grown virus exerts a favorable influence on the course of experimental trachoma infections. An antibody response to the vaccine was demonstrated and there was a modification of disease in the vounteers receiving vaccine. While the three volunteers who received placebo each developed cross infection of their uninoculated eye and had an acute reactivation of the bilateral disease after 1 to 2 months of antibiotic eye ointment therapy, the vaccinated volunteers remained free of infection in uninoculated eyes and showed no relapse after ointment therapy. Treatment with sulfamethoxypyridazine, a sulfa drug with prolonged action, proved to be an effective and relatively simple method of therapy for experimental trachoma. (Author)

Document Details

Document Type
Technical Report
Publication Date
Dec 29, 1961
Accession Number
AD0293164

Entities

People

  • J. Thomas Grayston
  • San-pin Wang

Organizations

  • Naval Medical Research Center

Tags

DTIC Thesaurus Topics

  • Antibodies
  • Bacterial Infections And Mycoses
  • Diseases And Disorders
  • Dosage Forms
  • Infection
  • Trachoma
  • Volunteers
  • Wound Infections

Fields of Study

  • Medicine

Readers

  • Immunology
  • Virology (or Medical Virology).

Technology Areas

  • Biotechnology